| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 523,228 | 548,103 | 677,964 | 670,460 | | Cost of Revenue | 33,349 | 44,730 | 44,175 | 54,637 | | | Gross Profit |
-
| 503,373 | 633,789 | 615,823 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 283,797 | 410,423 | 415,692 | 347,853 | | Non Recurring | 45,688 |
-
|
-
|
-
| | Others | 186,113 | 261,839 | 301,638 | 282,693 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (168,889) | (83,541) | (14,723) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (10,295) | (168,889) | (83,541) | (14,723) | | Interest Expense | 12,110 | 11,679 | 29,331 | 71,969 | | Income Before Tax | (37,829) | (180,568) | (112,872) | (86,692) | | Income Tax Expense | (14,519) | (74,538) | (47,777) | (30,988) | | Minority Interest | (8,563) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (23,310) | (106,030) | (65,095) | (55,704) | | | Non-recurring Events | | Discontinued Operations | (11,704) | 548 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (43,577) | (105,482) | (65,095) | (55,704) | | Preferred Stock And Other Adjustments | (9,283) | (17,699) | (17,706) | (7,413) | | | Net Income Applicable To Common Shares | ($52,860) | ($123,181) | ($82,801) | ($63,117) |
|
0.12% Nasdaq 
Income Statement
